Search

Jeffrey E. Russel

Examiner (ID: 13185, Phone: (571)272-0969 , Office: P/1675 )

Most Active Art Unit
1654
Art Unit(s)
1815, 1103, 1621, 1811, 1653, 1675, 2899, 1654, 1809
Total Applications
3437
Issued Applications
2371
Pending Applications
237
Abandoned Applications
837

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 3475267 [patent_doc_number] => 05428023 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-06-27 [patent_title] => 'Oral delivery of biologically active substances bound to vitamin B12 or analogues thereof' [patent_app_type] => 1 [patent_app_number] => 8/061343 [patent_app_country] => US [patent_app_date] => 1993-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4316 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/428/05428023.pdf [firstpage_image] =>[orig_patent_app_number] => 061343 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/061343
Oral delivery of biologically active substances bound to vitamin B12 or analogues thereof May 16, 1993 Issued
Array ( [id] => 3029863 [patent_doc_number] => 05349052 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-09-20 [patent_title] => 'Process for fractionating polyethylene glycol (PEG)-protein adducts and an adduct for PEG and granulocyte-macrophage colony stimulating factor' [patent_app_type] => 1 [patent_app_number] => 8/060889 [patent_app_country] => US [patent_app_date] => 1993-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 26 [patent_no_of_words] => 9389 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/349/05349052.pdf [firstpage_image] =>[orig_patent_app_number] => 060889 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/060889
Process for fractionating polyethylene glycol (PEG)-protein adducts and an adduct for PEG and granulocyte-macrophage colony stimulating factor May 11, 1993 Issued
08/058227 ANTIGENIC PREPARATION AND ISOLATION OF SUCH PREPARATIONS May 9, 1993 Pending
Array ( [id] => 3426725 [patent_doc_number] => 05422425 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-06-06 [patent_title] => 'Methods for the identification of cytokine convertase inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/053558 [patent_app_country] => US [patent_app_date] => 1993-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 6491 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/422/05422425.pdf [firstpage_image] =>[orig_patent_app_number] => 053558 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/053558
Methods for the identification of cytokine convertase inhibitors Apr 25, 1993 Issued
08/049481 IDENTIFICATION OF CELL DENSITY SIGNAL MOLECULE Apr 18, 1993 Pending
Array ( [id] => 3447097 [patent_doc_number] => 05420250 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-05-30 [patent_title] => 'Phase transfer process for producing native plasma protein concentrates' [patent_app_type] => 1 [patent_app_number] => 8/044585 [patent_app_country] => US [patent_app_date] => 1993-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14973 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/420/05420250.pdf [firstpage_image] =>[orig_patent_app_number] => 044585 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/044585
Phase transfer process for producing native plasma protein concentrates Apr 7, 1993 Issued
Array ( [id] => 2989481 [patent_doc_number] => 05366717 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-11-22 [patent_title] => 'Method for producing elemental sulfur from sulfur-containing gases' [patent_app_type] => 1 [patent_app_number] => 8/040077 [patent_app_country] => US [patent_app_date] => 1993-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4147 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/366/05366717.pdf [firstpage_image] =>[orig_patent_app_number] => 040077 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/040077
Method for producing elemental sulfur from sulfur-containing gases Mar 29, 1993 Issued
Array ( [id] => 4176669 [patent_doc_number] => 06084072 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-04 [patent_title] => 'Purified lectin and methods of use' [patent_app_type] => 1 [patent_app_number] => 8/041287 [patent_app_country] => US [patent_app_date] => 1993-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 15197 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/084/06084072.pdf [firstpage_image] =>[orig_patent_app_number] => 041287 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/041287
Purified lectin and methods of use Mar 29, 1993 Issued
Array ( [id] => 3007123 [patent_doc_number] => 05374715 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-12-20 [patent_title] => 'Method for forming proteoliposome and method for forming giant proteoliposome' [patent_app_type] => 1 [patent_app_number] => 8/032632 [patent_app_country] => US [patent_app_date] => 1993-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 7 [patent_no_of_words] => 8965 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/374/05374715.pdf [firstpage_image] =>[orig_patent_app_number] => 032632 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/032632
Method for forming proteoliposome and method for forming giant proteoliposome Mar 16, 1993 Issued
08/025216 COMPOSITIONS AND METHODS FOR TREATING WOUNDS Mar 1, 1993 Abandoned
Array ( [id] => 3522701 [patent_doc_number] => 05540919 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-30 [patent_title] => 'Method for enhancement of production of lymphokines and applications thereof' [patent_app_type] => 1 [patent_app_number] => 8/018471 [patent_app_country] => US [patent_app_date] => 1993-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 15 [patent_no_of_words] => 6056 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/540/05540919.pdf [firstpage_image] =>[orig_patent_app_number] => 018471 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/018471
Method for enhancement of production of lymphokines and applications thereof Feb 15, 1993 Issued
Array ( [id] => 3830467 [patent_doc_number] => 05760183 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-02 [patent_title] => 'Process for the manufacture of very high-purity antithaemophilic factor (FVIIIc), and von Willebrand factor, and pharmaceutical compositions containing same' [patent_app_type] => 1 [patent_app_number] => 8/016807 [patent_app_country] => US [patent_app_date] => 1993-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6364 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 316 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/760/05760183.pdf [firstpage_image] =>[orig_patent_app_number] => 016807 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/016807
Process for the manufacture of very high-purity antithaemophilic factor (FVIIIc), and von Willebrand factor, and pharmaceutical compositions containing same Feb 10, 1993 Issued
Array ( [id] => 3525113 [patent_doc_number] => 05504069 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-02 [patent_title] => 'Inhibition of trauma-induced tumor growth' [patent_app_type] => 1 [patent_app_number] => 8/016720 [patent_app_country] => US [patent_app_date] => 1993-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7974 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/504/05504069.pdf [firstpage_image] =>[orig_patent_app_number] => 016720 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/016720
Inhibition of trauma-induced tumor growth Feb 10, 1993 Issued
Array ( [id] => 3458463 [patent_doc_number] => 05401833 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-03-28 [patent_title] => 'Method and apparatus for treating chrome leather waste' [patent_app_type] => 1 [patent_app_number] => 8/012003 [patent_app_country] => US [patent_app_date] => 1993-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 3925 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/401/05401833.pdf [firstpage_image] =>[orig_patent_app_number] => 012003 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/012003
Method and apparatus for treating chrome leather waste Jan 31, 1993 Issued
Array ( [id] => 3418043 [patent_doc_number] => 05434139 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-07-18 [patent_title] => 'Detection of heparin-binding seminal plasma proteins' [patent_app_type] => 1 [patent_app_number] => 8/005869 [patent_app_country] => US [patent_app_date] => 1993-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 18 [patent_no_of_words] => 11489 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/434/05434139.pdf [firstpage_image] =>[orig_patent_app_number] => 005869 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/005869
Detection of heparin-binding seminal plasma proteins Jan 14, 1993 Issued
07/997113 SCAVENGER RECEPTOR PROTEIN AND ANTIBODY THERETO Dec 23, 1992 Abandoned
Array ( [id] => 3654953 [patent_doc_number] => 05658714 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-19 [patent_title] => 'Isolation of proteins by ultrafiltration' [patent_app_type] => 1 [patent_app_number] => 7/997616 [patent_app_country] => US [patent_app_date] => 1992-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8496 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 283 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/658/05658714.pdf [firstpage_image] =>[orig_patent_app_number] => 997616 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/997616
Isolation of proteins by ultrafiltration Dec 22, 1992 Issued
07/991137 COLLAGEN-BASED SORBENT POLYMER AND METHOD OF PREPARING SAME Dec 15, 1992 Abandoned
Array ( [id] => 3010742 [patent_doc_number] => 05276138 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-01-04 [patent_title] => 'Process for solubilizing animal hair' [patent_app_type] => 1 [patent_app_number] => 7/993522 [patent_app_country] => US [patent_app_date] => 1992-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3818 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/276/05276138.pdf [firstpage_image] =>[orig_patent_app_number] => 993522 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/993522
Process for solubilizing animal hair Dec 15, 1992 Issued
Array ( [id] => 4190010 [patent_doc_number] => 06153589 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-28 [patent_title] => '2,3-epoxy alcohols, acids and derivatives as anti retroviral chemotherapeutic agents' [patent_app_type] => 1 [patent_app_number] => 7/991251 [patent_app_country] => US [patent_app_date] => 1992-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13986 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/153/06153589.pdf [firstpage_image] =>[orig_patent_app_number] => 991251 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/991251
2,3-epoxy alcohols, acids and derivatives as anti retroviral chemotherapeutic agents Dec 14, 1992 Issued
Menu